| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $538.3M | +9.0% |
| Cost of Revenue | $398.1M | +18.7% |
| Gross Profit | $140.2M | -11.7% |
| R&D Expense | $3.9M | +14.7% |
| SG&A Expense | $99.7M | -11.8% |
| Operating Income | -$24.6M | -208.0% |
| Pre-tax Income | -$53.0M | -650.1% |
| Income Tax | $5.8M | +181.0% |
| Net Income | -$58.8M | — |
| EPS (Basic) | -$1.42 | — |
| EPS (Diluted) | -$1.42 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.7M | +1.3% |
| Accounts Receivable | $66.7M | -4.2% |
| Inventory | $219.0M | +2.8% |
| Current Assets | $324.8M | +2.0% |
| Total Assets | $849.0M | -8.0% |
| Current Liabilities | $87.0M | -42.6% |
| Long-term Debt | $435.9M | +12.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | -161.3% |
| Investing Cash Flow | -$8.4M | +95.7% |
| Financing Cash Flow | $16.5M | -91.7% |
| Total Liabilities |
| $574.5M |
| -5.6% |
| Stockholders' Equity | $274.6M | -12.5% |